“The adoption of the Exclusive Sale Rights will only benefit pharmaceutical companies”

Published: 2014-12-12 13:27:48

Updated: 2014-12-12 13:30:49

The pharmaceutical industry has paid attention on enforcement of the Patent Linkage System and the ‘Exclusive Sale Rights’ of the system.

The Korea Pharmaceutical Manufacturers Association (KPMA) held a press conferenceto explain an importance of the adoption of the ‘Exclusive Sale Rights’ and released a policy recommendation that will be submitted to the National Assembly.

The Selling Restri...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.